Humira (adalimumab) is administered as an injection under the skin and has been FDA-approved for treating plaque psoriasis and psoriatic arthritis since 2005. While many people have found success with this medication, experiences can vary.
Some MyPsoriasisTeam members have reported hair loss as a potential side effect Show Full Answer
Humira (adalimumab) is administered as an injection under the skin and has been FDA-approved for treating plaque psoriasis and psoriatic arthritis since 2005. While many people have found success with this medication, experiences can vary.
Some MyPsoriasisTeam members have reported hair loss as a potential side effect, though this is considered rare. More common side effects can include injection site reactions and potential increased risk of infections. Recent research suggests that newer biologic medications may have fewer side effects compared to Humira. Studies show that medications like guselkumab, risankizumab, tildrakizumab, ixekizumab, and ustekinumab had lower rates of adverse events.
It's important to note that some people may eventually stop responding to Humira, as shared by some community members. Always work closely with your healthcare provider to monitor your response to treatment and discuss any concerns about side effects.
September 16, 2025
Join
Your Privacy Choices
